Publication:
Doxorubicin-induced hepatic and renal cellar damage could be protected by the usage of antioxidant agents (vitamin E and C) in breast cancer patients

Simple item page
dc.contributor.authorsAl-Taie, A. H.; Abdulrazzaq, H. A.
dc.date.accessioned2022-03-10T17:52:00Z
dc.date.accessioned2026-01-11T09:02:51Z
dc.date.available2022-03-10T17:52:00Z
dc.date.issued2013
dc.identifier.doidoiWOS:000328208800269
dc.identifier.eissn2210-7711
dc.identifier.issn2210-7703
dc.identifier.urihttps://hdl.handle.net/11424/221544
dc.identifier.wosWOS:000328208800269
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDoxorubicin-induced hepatic and renal cellar damage could be protected by the usage of antioxidant agents (vitamin E and C) in breast cancer patients
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage1347
oaire.citation.issue6
oaire.citation.startPage1347
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
oaire.citation.volume35

Files

Collections

Araştırma Çıktıları